These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8027974)

  • 21. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
    Dowd CS; Herrick-Davis K; Egan C; DuPre A; Smith C; Teitler M; Glennon RA
    J Med Chem; 2000 Aug; 43(16):3074-84. PubMed ID: 10956215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
    Runyon SP; Savage JE; Taroua M; Roth BL; Glennon RA; Westkaemper RB
    Bioorg Med Chem Lett; 2001 Mar; 11(5):655-8. PubMed ID: 11266163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).
    Luethi D; Trachsel D; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):141-148. PubMed ID: 28720478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
    Herndon JL; Ismaiel A; Ingher SP; Teitler M; Glennon RA
    J Med Chem; 1992 Dec; 35(26):4903-10. PubMed ID: 1479590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
    J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New halogenated tris-(phenylalkyl)amines as h5-HT2B receptor ligands.
    Kapadia N; Ahmed S; Harding WW
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3216-3219. PubMed ID: 27261181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.
    Nichols DE; Frescas SP; Chemel BR; Rehder KS; Zhong D; Lewin AH
    Bioorg Med Chem; 2008 Jun; 16(11):6116-23. PubMed ID: 18468904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ring-constrained phenylpropyloxyethylamines on sigma receptors.
    Stavitskaya L; Seminerio MJ; Healy JR; Noorbakhsh B; Matsumoto RR; Coop A
    Bioorg Med Chem; 2013 Sep; 21(17):4923-7. PubMed ID: 23896610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
    Bromidge SM; Dabbs S; Davies DT; Davies S; Duckworth DM; Forbes IT; Gaster LM; Ham P; Jones GE; King FD; Mulholland KR; Saunders DV; Wyman PA; Blaney FE; Clarke SE; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Trail B; Riley GJ; Wood MD
    J Med Chem; 2000 Mar; 43(6):1123-34. PubMed ID: 10737744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 3-(2-N,N-diethylaminoethoxy)indoles as potential 5-HT6 receptor ligands.
    Alex K; Schwarz N; Khedkar V; Sayyed IA; Tillack A; Michalik D; Holenz J; Díaz JL; Beller M
    Org Biomol Chem; 2008 May; 6(10):1802-7. PubMed ID: 18452016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
    Glennon RA; Raghupathi R; Bartyzel P; Teitler M; Leonhardt S
    J Med Chem; 1992 Feb; 35(4):734-40. PubMed ID: 1542100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
    Johnson MP; Loncharich RJ; Baez M; Nelson DL
    Mol Pharmacol; 1994 Feb; 45(2):277-86. PubMed ID: 8114677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents.
    Mokrosz MJ; Mokrosz JL; Duszyńska B; Dereń-Wesołek A; Kłodzińska A; Kowalski P; Charakchieva-Minol S; Tatarczyńska E; Kowalska T; Majka Z; Chojnacka-Wójcik E; Misztal S
    Pharmazie; 1997 Jun; 52(6):423-8. PubMed ID: 9260266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions.
    Kristiansen K; Dahl SG
    Eur J Pharmacol; 1996 Jun; 306(1-3):195-210. PubMed ID: 8813633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ
    Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
    Noda-Saita K; Matsumoto M; Hidaka K; Hatanaka K; Ohmori J; Okada M; Yamaguchi T
    Biochem Biophys Res Commun; 1999 Feb; 255(2):367-70. PubMed ID: 10049714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
    Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
    J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.